- Home
- GWH vs ATNM Comparison
GWH vs ATNM Comparison
Compare GWH & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GWH
- ATNM
- Stock Information
- Founded
- GWH 2011
- ATNM 2000
- Country
- GWH United States
- ATNM United States
- Employees
- GWH N/A
- ATNM N/A
- Industry
- GWH Industrial Machinery/Components
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- GWH Miscellaneous
- ATNM Health Care
- Exchange
- GWH Nasdaq
- ATNM Nasdaq
- Market Cap
- GWH 63.2M
- ATNM 56.5M
- IPO Year
- GWH N/A
- ATNM N/A
- Fundamental
- Price
- GWH $5.50
- ATNM $1.22
- Analyst Decision
- GWH Buy
- ATNM Strong Buy
- Analyst Count
- GWH 6
- ATNM 4
- Target Price
- GWH $2.54
- ATNM $8.75
- AVG Volume (30 Days)
- GWH 71.5K
- ATNM 241.3K
- Earning Date
- GWH 03-12-2025
- ATNM 11-14-2024
- Dividend Yield
- GWH N/A
- ATNM N/A
- EPS Growth
- GWH N/A
- ATNM N/A
- EPS
- GWH N/A
- ATNM N/A
- Revenue
- GWH $6,241,000.00
- ATNM $81,000.00
- Revenue This Year
- GWH $32.11
- ATNM $138.42
- Revenue Next Year
- GWH $341.09
- ATNM $16,957.05
- P/E Ratio
- GWH N/A
- ATNM N/A
- Revenue Growth
- GWH 31.11
- ATNM N/A
- 52 Week Low
- GWH $4.35
- ATNM $1.10
- 52 Week High
- GWH $16.50
- ATNM $10.24
- Technical
- Relative Strength Index (RSI)
- GWH 48.82
- ATNM 43.29
- Support Level
- GWH $5.18
- ATNM $1.30
- Resistance Level
- GWH $5.82
- ATNM $1.35
- Average True Range (ATR)
- GWH 0.41
- ATNM 0.08
- MACD
- GWH 0.01
- ATNM -0.00
- Stochastic Oscillator
- GWH 50.08
- ATNM 19.23
About GWH ESS Tech Inc.
ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. The company design and produce long-duration batteries predominantly using earth-abundant materials.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.